Cancer Prevention Research, the newest journal from the American Association for Cancer Research, is devoted exclusively to cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of oncogenesis, risk factors and risk assessment, early detection research, and chemopreventive and other interventions, including the basic science behind them. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.
Cancer/radiothérapie se veut d'abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique. La revue publie 6 numéros par an ainsi qu'un numéro spécial à l'occasion du congrès annuel de la SFRO.
Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer. Subject categories include:
Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.Each issue provides topical reviews under the following regular sections:• Comments on controversy;• Tumor reviews;• Anti-tumor treatments;• New drugs;• Complications of treatment;• General and supportive care;• Laboratory/clinic interface.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.
Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.
Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer and metabolism, including:Molecular biology and genetics of cancer metabolismWhole-body metabolism, including diabetes and obesity, in relation to cancerMetabolomics in relation to cancerMetabolism-based imagingPreclinical and clinical studies of metabolism-related cancer therapies
The transformation of biology from a descriptive, phenomenological discipline to one in which the regulatory principles are understood and predictably manipulated brings new opportunities to the study of cancer and the search for effective therapeutic modalities. Cancer and Metastasis Reviews offers a forum for critical review and discussion of these challenges.Each issue presents five to seven different contributions on a single theme or topic, with an introductory essay from a distinguished individual in the field. Special emphasis is placed on subjects of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.The journal also reviews important recent developments in the biology and treatment of malignant disease, and highlights promising new directions.
Cells (ISSN 2072-6694) is an international, peer-reviewed open access journal which provides an advanced forum for studies related to cell biology, molecular biology and biophysics. It publishes reviews, research articles, communications and technical notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. Full experimental and/or methodical details must be provided. There are, in addition, unique features of this journal:, , manuscripts regarding research proposals and research ideas will be particularly welcomed, electronic files or software regarding the full details of the calculation and experimental procedure - if unable to be published in a normal way - can be deposited as supplementary material, we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Carbohydrate Research publishes outstanding and timely research reports on molecular aspects of carbohydrate chemistry, biochemistry, chemical biology and glycobiology.Areas of interest include:• Sugars, glycosides and their derivatives; oligo- and poly-saccharides; glycoconjugates• Chemical and enzymatic synthesis of carbohydrate-containing molecules. • Isolation and structural characterization of novel carbohydrate-containing molecules• Experimental and theoretical studies on structure, dynamics and mechanism• Analytical chemistry and biochemistry, including molecular probes• Studies of carbohydrate-processing, including enzyme action, mechanism and inhibition• Glycobiology, glycan metabolism and biosynthesis• Glycomics and glycoinformatics• Molecular aspects of glycoimmunochemistry• Molecular aspects of glyconanoparticles and carbohydrate materialsThe journal includes full-length research papers, reviews and notes, all of which are subjected to rigorous peer review prior to acceptance. Molecular-level characterization of all materials under investigation is required.It is now possible to submit your paper online and benefit from considerably shorter review and publication times. For further information please visit http://www.elsevier.com/authors
Carcinogenesis: Integrative Cancer Research is a multi-disciplinary journal that brings together all the varied aspects of research that will ultimately lead to the prevention of cancer in man. The journal will publish papers that warrant prompt publication in the areas of Cancer Biology (including the processes of promotion, progression, signal transduction, apoptosis, genomic instability, growth factors, cell and molecular biology, mutation, DNA repair, genetics, etc.), Molecular Epidemiology (including genetic predisposition to cancer, and epidemiology), Cancer Prevention (including molecular dosimetry, chemoprevention, nutrition and cancer, etc.), and Carcinogenesis (including viral, chemical and physical carcinogenesis, metabolism of carcinogens, and the formation, detection, identification and quantification of environmental carcinogens).
Cardiac Electrophysiology Clinics provides you with practical, hands-on advice on the evaluation and management of patients with heart rhythm disorders. Each issue provides expert, state-of-the-art discussions on a single topic relevant to your practice. You'll find clear, comprehensive coverage on valuable topics such as sudden cardiac death, diagnostic evaluation of arrhythmias, advances in arrhythmia analysis, arrhythmias in special populations, antiarrhythmic drug therapy, cardiac pacing and defibrillation, genetics and pharmacogentics, and much more.Cardiac Electrophysiology Clinics is published four times a year—March, June, September, and December.
The journal of ‘CardioRenal Medicine’ explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues. Attention is paid to the fact that some metabolic abnormalities cluster with heart and chronic kidney disease, and collectively this is called the cardiorenal metabolic syndrome. Moreover, certain metabolic abnormalities of the heart promote impaired coronary artery endothelial function, diastolic dysfunction and ischemic reconditioning that parallel glomerular hyperfiltration and impairments in proximal tubule handling of sodium and albumin. Another point of focus is the role of the obesity epidemic in promoting the increasing incidence of heart and kidney disease in industrialized countries and the prevailing problems of insufficient exercise and excessive consumption of cheap, unwholesome food in promotion of the cardiorenal metabolic syndrome in both adults and children.
CardioVascular and Interventional Radiology publishes peer-reviewed original research work including laboratory and clinical investigations, technical notes, case reports, brief communications, and letters to the editor, as well as review articles, opinions, editorials, and special invited submissions in the field of cardiac, vascular, and interventional radiology. This is the official journal of the Cardiovascular and Interventional Radiological Society of Europe, the Japanese Society of Interventional Radiology, and the British Society of Interventional Radiology.
Established in 1937, Cardiology provides a forum for scientific progress in the prevention, recognition, and treatment of heart disease. Bridging clinical, preclinical, and translational research, the contents include original research articles, topical reviews, and expert opinion commentaries. Sections such as “Coronary Artery Disease”, “Imaging”, “Electrophysiology and Arrhythmia”, or “eCardiology/Digital Health” highlight the wide variety of subspecialty areas covered and feature new developments in noninvasive and invasive diagnostic methods, epidemiology, as well as pharmacological, preventive, and mechanical/surgical therapies.
Cardiology publishes articles relevant to cardiologists, cardiac surgeons, internists, clinical physiologists, pharmacologists, and professionals from other areas of medicine interested in cardiovascular diseases.
Published four times a year—in February, May, August, and November—Cardiology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Tailored to meet the needs of those in the field of cardiology, each issue focuses on a single cardiology topic, including acute coronary syndromes/cardiac emergencies, coronary artery disease, heart failure, heart rhythm disorders, and much more.
Cardiology Journal (formelly Folia Cardiologica) is a scientific, peer-reviewed journal covering a broad spectrum of topics in cardiology. The journal has been published since 1994 and over the years it has become an internationally recognized journal of cardiological and medical community. This growing interest in Cardiology Journal is mostly due to constantly increasing quality of original papers submitted to the journal from all-over-the-world, excellent educational content with interesting review and how to do articles, and instructional case reports. Cardiology Journal is the journal for practicing cardiologists, researchers, and young trainees benefiting from broad spectrum of useful educational content. All these factors led the journal to receiving an international indexation in Medline, EMBASE, Index Copernicus (9.00), PBL GBL and Thomson Reuters database. The journal remains an official journal of several Working Groups of the Polish Cardiac Society.